Tag Archives: Singapore

GREAT BRITAIN – StemWay Biotech criticizes Italian government on umbilical cord stem cells

The Health Minister recently held a press conference to launch a program to strengthen the public biobank network, considering that currently on 20% of donations are completed successfully. An informative pamphlet was also distributed about “The appropriate use of umbilical cord stem cells“.

The StemWay Biotech company, through its Vice-President Dr. Paolo Rubini, in complete agreement with other biobanks in Italy, with great surprise and dismay, stressed that unfortunately, the measure seems to be more against the autologous conservation of stem cells rather than in favor of donation. As for the scientific statements contained in the informative pamphlet
Read More…

Scientists Lead Human Embryonic Stem Cell Study to Advance the Field of Regenerative Medicine Research

Researchers from A*STAR Singapore took lead roles in a study that identified a portion of the genome mutated during long-term culture of human embryonic stem cells (hESCs). The study was a worldwide collaboration, led by Drs Peter Andrews of the University of Sheffield (UK), Paul Robson of the Genome Institute of Singapore (GIS), Steve Oh of Singapore’s Bioprocessing Technology Institute (BTI), and Barbara Knowles and others in the international stem cell community. The GIS, IMB and BTI are research institutes under the umbrella of the Agency for Science, Technology and Research, (A*STAR), Singapore.

Involving 125 ethnically diverse hESC lines originating
Read More…